Table 1 Reported complications with COVID-19
From: ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review
Total number of patients | Venovenous ECMO % | Pulmonary complications | Cardiovascular complications | Other complications | |
|---|---|---|---|---|---|
Huang C [27] | 41 hospitalised | NA | ARDS (29%) | Acute cardiac injury (12%)a Shock (7%) | AKI (7%) Secondary infection (10%) |
Wang D [28] | 138 hospitalised | NA | ARDS (19.6%) | Shock (8.7%), Acute cardiac injury (7.2%), Arrhythmia (16.7%) | AKI (3.6%) |
Yang X [29] | 52 ICU admitted | NA | ARDS (67%) Hospital acquired pneumonia (11.5%) Pneumothorax (2%) | Cardiac injury (23%) | AKI (29%) Liver dysfunction (29%) Hyperglycaemia (35%) GI haemorrhage (4%) Bacteremia (2%) Urinary tract infection (2%) |
Zhou F [30] | 191 hospitalised | NA | Respiratory failure (54%) ARDS (31%) | Heart failure (23%) Acute cardiac injury (17%) Septic shock (20%) | Sepsis (59%) Coagulopathy (19%) Acute kidney injury (15%) Secondary infection (15%) Hypoproteinemia (12%) Acidosis (9%) |
Varga Z [32] | 3 cases | No ECMO | Respiratory failure (3) | Endothelitis in organ vessels (3) Myocardial infarction (1) Reduced LV EF and circulatory collapse (1) | Mesenteric ischemia (2) Multiorgan failure (1) |
Xie Y [31] | 2 cases | No ECMO | Pulmonary embolism (2) | ||
Hua A [33] | 1 case | No ECMO | Myopericarditis (1) Cardiac tamponade Pericardial effusion | ||
Inciardi RM [34] | 1 case | No ECMO | Myopericarditis with systolic dysfunction (1) |